Bioporto As Stock Performance
| THOXF Stock | USD 0.15 0.14 48.28% |
The firm shows a Beta (market volatility) of -0.0908, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioPorto are expected to decrease at a much lower rate. During the bear market, BioPorto is likely to outperform the market. At this point, BioPorto AS has a negative expected return of -0.78%. Please make sure to confirm BioPorto's jensen alpha and day median price , to decide if BioPorto AS performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days BioPorto AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 107.9 M | |
| Total Cashflows From Investing Activities | -412 K |
BioPorto |
BioPorto Relative Risk vs. Return Landscape
If you would invest 29.00 in BioPorto AS on November 8, 2025 and sell it today you would lose (14.00) from holding BioPorto AS or give up 48.28% of portfolio value over 90 days. BioPorto AS is currently producing negative expected returns and takes up 6.131% volatility of returns over 90 trading days. Put another way, 55% of traded pink sheets are less volatile than BioPorto, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioPorto Target Price Odds to finish over Current Price
The tendency of BioPorto Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.15 | 90 days | 0.15 | close to 99 |
Based on a normal probability distribution, the odds of BioPorto to move above the current price in 90 days from now is close to 99 (This BioPorto AS probability density function shows the probability of BioPorto Pink Sheet to fall within a particular range of prices over 90 days) .
BioPorto Price Density |
| Price |
Predictive Modules for BioPorto
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioPorto AS. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioPorto's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioPorto Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioPorto is not an exception. The market had few large corrections towards the BioPorto's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioPorto AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioPorto within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.74 | |
β | Beta against Dow Jones | -0.09 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.13 |
BioPorto Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioPorto for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioPorto AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioPorto AS generated a negative expected return over the last 90 days | |
| BioPorto AS has high historical volatility and very poor performance | |
| BioPorto AS has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 24.25 M. Net Loss for the year was (57.11 M) with profit before overhead, payroll, taxes, and interest of 15.04 M. | |
| BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
BioPorto Fundamentals Growth
BioPorto Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioPorto, and BioPorto fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioPorto Pink Sheet performance.
| Return On Equity | -0.88 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.50) % | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 106.91 M | |||
| Shares Outstanding | 334.68 M | |||
| Price To Book | 12.43 X | |||
| Price To Sales | 9.27 X | |||
| Revenue | 24.25 M | |||
| EBITDA | (58.6 M) | |||
| Cash And Equivalents | 86.72 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 10.42 M | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | (64.58 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 81.25 M | |||
About BioPorto Performance
By analyzing BioPorto's fundamental ratios, stakeholders can gain valuable insights into BioPorto's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioPorto has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioPorto has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.Things to note about BioPorto AS performance evaluation
Checking the ongoing alerts about BioPorto for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioPorto AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioPorto AS generated a negative expected return over the last 90 days | |
| BioPorto AS has high historical volatility and very poor performance | |
| BioPorto AS has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 24.25 M. Net Loss for the year was (57.11 M) with profit before overhead, payroll, taxes, and interest of 15.04 M. | |
| BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing BioPorto's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioPorto's stock is overvalued or undervalued compared to its peers.
- Examining BioPorto's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioPorto's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioPorto's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioPorto's pink sheet. These opinions can provide insight into BioPorto's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioPorto Pink Sheet analysis
When running BioPorto's price analysis, check to measure BioPorto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPorto is operating at the current time. Most of BioPorto's value examination focuses on studying past and present price action to predict the probability of BioPorto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPorto's price. Additionally, you may evaluate how the addition of BioPorto to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |